microarray
simpli
defin
collect
microscop
spot
featur
biolog
captur
molecul
dna
protein
spatial
arrang
predefin
order
solid
substrat
dna
microarray
also
known
dna
chip
biochip
spot
contain
predefin
short
singlestrand
dna
oligonucleotid
larger
doublestrand
dna
known
probe
microarray
experi
consist
hybridis
sampl
target
dna
solut
whose
ident
abund
sought
typic
larg
number
probe
fix
substrat
target
dna
molecul
prepar
fluoresc
tag
microarray
expos
result
mixtur
condit
favour
hybridis
unbound
dna
fragment
wash
away
microarray
posit
dnadna
hybrid
detect
optic
indic
compon
present
start
sampl
microarray
experi
therefor
larg
number
hybridis
experi
done
parallel
microarray
thought
highli
parallel
processor
biolog
queri
variou
microarray
method
avail
differ
type
probe
solid
support
method
use
address
probe
detect
target
miller
tang
microarray
technolog
commonli
use
detect
identif
microbi
target
includ
solidst
microarray
electron
microarray
suspens
bead
microarray
detail
technolog
includ
probe
length
number
possibl
featur
densiti
surfac
chemistri
employ
describ
compar
tabl
chapter
review
concept
behind
microarray
technolog
describ
clinic
applic
microarray
analysi
pathogen
detect
genotyp
antimicrobi
resist
test
microbiolog
laboratori
goldmann
gonzalez
laust
et
al
situ
synthesis
photolithograph
mask
probe
synthesis
parallel
directli
solid
surfac
phosphoramidit
protect
deprotect
chemistri
use
maskdirect
photolithographi
base
silicon
chip
beier
hoheisel
peas
et
al
situ
synthesis
digit
micromirror
probe
synthesis
parallel
directli
solid
surfac
phosphoramidit
protect
deprotect
chemistri
use
maskless
photodeprotect
digit
micromirror
devic
base
silicon
chip
singhgasson
et
al
situ
synthesis
inkjet
probe
synthesis
parallel
directli
solid
surfac
phosphoramidit
protect
deprotect
chemistri
use
acidmedi
chemic
deprotect
inkjet
print
base
glass
slide
hugh
et
al
electron
presynthesis
probe
transport
specif
locat
solid
surfac
electr
field
immobilis
streptavidinbiotin
bond
base
silicon
chip
sosnowski
tu
butler
oconnel
heller
edman
et
al
presynthesis
probe
coval
coupl
solid
surfac
base
polystyren
microspher
dunbar
dunbar
jacobson
print
spot
microarray
built
deposit
presynthesis
probe
onto
glass
slide
use
finepoint
pin
figur
goldmann
gonzalez
laust
et
al
probe
short
oligonucleotid
cdna
pcr
product
surfac
attach
chemistri
either
coval
noncoval
coval
attach
requir
addit
aliphat
amin
nh
group
end
probe
probe
attach
glass
end
noncoval
attach
involv
electrostat
attract
amin
group
glass
slide
phosphat
group
probe
backbon
noncoval
interact
strong
enough
tether
short
oligonucleotid
probe
glass
thu
noncoval
attach
appropri
cdna
microarray
deliveri
probe
onto
glass
slide
achiev
spot
robot
use
either
contact
noncontact
microarray
print
contact
print
technolog
use
sinc
earli
day
microarray
technolog
base
pin
tool
dip
sampl
solut
take
small
volum
sampl
brought
contact
slide
surfac
deliv
sampl
small
spot
current
avail
pin
deliv
spot
volum
nl
rang
result
spot
diamet
mm
noncontact
print
enabl
microarray
print
without
direct
contact
surfac
use
piezoelectr
bubblegener
microsolenoiddriven
dispens
work
principl
inkjet
printer
system
capabl
dispens
singl
drop
volum
sever
hundr
picolitr
probe
print
surfac
array
usual
chemic
modifi
fix
make
attach
addit
dna
unfeas
fix
desir
avoid
nonspecif
bind
dna
target
sampl
glass
slide
hybridis
postproduct
modif
surfac
make
hydrophil
also
common
facilit
mix
target
dna
hybridis
probe
highdens
microarray
synthesis
basebybas
situ
solid
surfac
microarray
straightforward
method
synthesis
oligonucleotid
involv
ad
nucleotid
one
time
grow
end
oligonucleotid
chain
method
sequenc
oligonucleotid
chain
dictat
order
dntp
ad
reaction
solidphas
situ
chemic
synthesi
dna
altern
chemic
oligonucleotid
synthesi
base
phosphoramidit
protectiondeprotect
chemistri
coupl
solid
support
contain
coval
linker
molecul
beier
hoheisel
phosphoramidit
build
block
phosphoramidit
nucleosid
deriv
chemic
protect
deoxynucleosid
da
dc
dg
dt
use
phosphoramidit
protectiondeprotect
chemistri
protect
amin
phosphat
print
microarray
presynthesis
oligonucleotid
dna
probe
spot
onto
glass
slide
use
finepoint
pin
print
probe
chemic
fix
slide
b
sampl
contain
target
dna
process
extract
label
hybridis
microarray
c
hybridis
microarray
scan
raw
imag
process
analys
hydroxyl
reactiv
group
ensur
prevent
unwant
side
reaction
protect
exocycl
amino
group
standard
scheme
use
benzoyl
group
adenosin
cytidin
isobutyryl
group
guanosin
thymidin
reactiv
exocycl
amino
group
henc
need
protect
situ
synthesi
oligonucleotid
chain
use
protectiondeprotect
chemistri
consist
reaction
cycl
cycl
reaction
result
addit
singl
base
base
ad
protect
group
end
prevent
addit
one
base
round
synthesi
initi
stage
termin
base
coval
attach
solid
support
oligonucleotid
synthesis
direct
oppos
direct
dna
replic
repeat
synthesi
cycl
mani
time
requir
desir
length
dna
achiev
protectiondeprotect
synthesi
cycl
follow
four
conceptu
step
deprotect
protect
group
termin
nucleotid
remov
yield
reactiv
hydroxyl
oh
readi
bond
yet
ad
phosphoramidit
coupl
activ
nucleosid
phosphoramidit
brought
contact
supportbound
oligonucleotid
precursor
oh
group
react
activ
phosphoramidit
moieti
form
phosphit
triester
bond
unstabl
linkag
oligonucleotid
end
coupl
reaction
small
fraction
oh
group
remain
unreact
fraction
newli
ad
base
actual
incorpor
grow
dna
chain
call
coupl
effici
one
desir
properti
highyield
nucleotid
synthesi
scheme
high
coupl
effici
cap
perman
block
unreact
oh
group
treat
chemic
catalyst
mixtur
oxid
phosphit
triester
bond
form
coupl
unstabl
oligonucleotid
synthesi
condit
oxid
step
involv
oxid
trival
phosphit
stabl
pentaval
phosphat
differ
method
use
deprotect
step
result
three
technolog
situsynthesis
microarray
three
technolog
differ
whether
use
photoor
acidlabil
protect
group
oh
group
nucleosid
phosphoramidit
achiev
combinatori
chemistri
involv
parallel
synthesi
thousand
probe
method
form
basi
affymetrix
genechip
technolog
light
use
convert
protect
group
termin
nucleotid
oh
group
figur
round
synthesi
select
exposur
specif
array
locat
featur
light
achiev
physic
chromium
mask
allow
light
reach
certain
area
microarray
techniqu
known
photolithographi
adapt
manufactur
silicon
microprocessor
chip
beier
hoheisel
peas
et
al
featur
expos
light
becom
activ
synthesi
microarray
surfac
flush
solut
contain
singl
type
nucleotid
chemic
coupl
occur
featur
deprotect
newli
coupl
nucleotid
also
protect
group
process
repeat
applic
anoth
mask
subsequ
flush
anoth
nucleotid
probe
fulli
synthesis
probe
microarray
requir
four
mask
per
round
synthesi
probe
affymetrix
genechip
microarray
nucleotid
long
requir
nearli
mask
per
microarray
photolithograph
mask
expens
produc
design
manufactur
reus
make
larg
number
ident
microarray
high
fidel
thu
affymetrix
genechip
technolog
well
posit
make
larg
number
standardis
microarray
maskless
photodeprotect
also
base
lightdirect
synthesi
use
digit
micromirror
devic
select
light
exposur
array
featur
singhgasson
et
al
method
behind
roch
nimblegen
maskless
array
situsynthesis
microarray
use
maskassist
photolithographi
top
lithograph
mask
use
transmit
block
uv
light
chemic
protect
nucleotid
microarray
surfac
bottom
protect
group
circl
remov
uv
exposur
allow
addit
singl
protect
nucleotid
squar
cycl
repeat
use
differ
mask
sequenti
dictat
order
nucleotid
sequenc
oligonucleotid
probe
synthesis
ma
technolog
digit
micromirror
devic
solidst
silicon
devic
array
aluminium
mirror
comput
control
direct
light
desir
locat
solid
microarray
surfac
figur
effect
creat
virtual
mask
replac
standard
photolithograph
mask
nimblegen
digit
micromirror
devic
abl
pattern
individu
pixel
light
enabl
minimum
featur
size
mm
sinc
physic
mask
produc
primari
expens
maskless
approach
chemistri
flexibl
virtual
mask
enabl
product
small
batch
highdens
microarray
differ
array
layout
matter
day
maskless
situsynthesis
microarray
use
digit
micromirror
digit
micromirror
technolog
use
creat
virtual
mask
photodeprotect
uv
light
direct
mask
imag
onto
microarray
surfac
remov
protect
group
circl
allow
addit
singl
nucleotid
squar
step
repeat
differ
virtual
mask
direct
synthesi
desir
oligonucleotid
select
pattern
method
underli
agil
technolog
microarray
coupl
chemic
acidmedi
deprotect
inkjet
print
deposit
basepair
oligonucleotid
one
base
time
standard
glass
slide
hugh
et
al
deprotect
dmtprotect
nucleosid
phosphoramidit
achiev
remov
dmt
trichloroacet
acid
coupl
step
synthesi
cycl
inkjet
printer
use
tini
nozzl
monom
chemic
activ
place
picolitr
drop
reagent
specifi
locat
microarray
figur
micromirror
inkjet
technolog
allow
comput
control
synthesi
featur
time
array
product
photolithographi
requir
physic
premad
mask
make
former
technolog
highli
flexibl
technolog
less
effici
make
larg
batch
ident
array
compar
photolithograph
mask
variant
phosphoramiditebas
synthesi
differ
coupl
effici
yield
desir
probe
depend
length
oligonucleotid
synthesis
low
coupl
effici
longer
probe
eventu
yield
fulllength
oligo
becom
unaccept
low
photodeprotect
acidmedi
deprotect
dimethoxytrityl
protect
group
coupl
effici
approxim
respect
mcgall
et
al
chemic
deprotect
use
inkjetmedi
synthesi
allow
inkjet
technolog
suitabl
highfidel
synthesi
longer
oligonucleotid
situsynthesis
microarray
use
chemic
deprotect
inkjetmedi
synthesi
method
use
acidmedi
deprotect
inkjet
print
oligonucleotid
probe
synthesi
printer
use
tini
nozzl
deposit
picolitr
amount
nucleotid
reagent
specifi
locat
microarray
repeat
round
print
extend
probe
length
nucleotid
print
situsynthesis
microarray
reli
passiv
transport
hybridis
nucleic
acid
contrast
electron
microarray
utilis
activ
hybridis
via
electr
field
control
nucleic
acid
transport
figur
commerci
avail
nanochip
xl
savyon
diagnost
formerli
nanochip
nanogen
inc
core
technolog
microelectron
cartridg
use
complementari
metal
oxid
semiconductor
technolog
electron
address
nucleic
acid
cartridg
connector
control
individu
test
site
microarray
gener
transport
neg
charg
nucleic
acid
specif
site
electr
field
appli
one
test
site
microarray
edman
et
al
surfac
microarray
contain
streptavidin
allow
format
streptavidinbiotin
bond
biotinyl
probe
reach
locat
applic
specif
electr
field
thu
immobilis
probe
onto
surfac
electr
field
remov
activ
featur
new
test
site
activ
probe
hybridis
discret
test
site
microarray
readi
applic
fluoresc
label
target
dna
target
dna
electron
microarray
left
posit
current
appli
specif
test
site
pad
assist
movement
neg
charg
dna
probe
activ
pad
probe
attach
streptavidinbiotin
bind
site
deactiv
current
appli
differ
pad
localis
new
probe
process
repeat
probe
array
right
sampl
extract
amplifi
hybridis
microarray
surfac
targetspecif
secondari
probe
fluoresc
detector
oligonucleotid
use
measur
posit
hybridis
reaction
passiv
hybridis
immobilis
probe
microarray
concentr
electron
barlaan
sugimori
furukawa
takeuchi
kumar
et
al
electron
address
captur
probe
first
commonli
use
assay
format
amplicon
first
sandwich
assay
also
describ
feng
nerenberg
hybridis
occur
probe
target
dna
fluoresc
report
present
posit
test
site
detect
electron
microarray
scan
analys
imag
instrument
use
chargecoupl
devic
ccd
camera
data
collect
analysi
softwar
suspens
bead
microarray
technolog
threedimension
array
use
microparticl
microspher
bead
solid
support
bind
reaction
flow
cytometri
ccd
imag
detect
bead
associ
target
figur
particl
distinguish
subset
differ
classif
featur
intern
absorb
fluorophor
size
diamet
surfac
composit
characterist
multiplex
achiev
uniqu
featur
particl
subset
xmap
technolog
platform
luminex
beadbas
suspens
microarray
technolog
commonli
use
detect
nucleic
acid
utilis
polystyren
microspher
intern
dy
two
three
spectral
distinct
fluorochrom
dunbar
use
precis
amount
fluorochrom
array
creat
consist
differ
bead
set
specif
spectral
address
specif
captur
oligonucleotid
probe
coval
coupl
surfac
specif
bead
set
bead
set
precoupl
uniqu
captur
oligonucleotid
commerci
avail
nucleic
acid
microarray
assay
develop
target
nucleic
acid
captur
hybridis
complementari
probe
sequenc
label
report
molecul
ie
fluoresc
dye
allow
detect
quantit
specif
bind
occur
particl
surfac
multipl
read
made
per
bead
set
target
provid
fluoresc
output
signal
hybridis
result
varieti
assay
chemistri
use
gener
dna
target
suspens
bead
hybridis
includ
direct
captur
competit
hybridis
solutionbas
enzymat
chemistri
combin
univers
captur
probe
figur
direct
hybridis
label
pcramplifi
target
dna
bead
set
bear
specif
oligonucleotid
captur
probe
simpl
commonli
use
assay
chemistri
typic
employ
probe
approxim
nucleotid
length
dunbar
dunbar
jacobson
probe
complementari
sequenc
label
strand
pcr
product
polymorph
nucleotid
suspens
bead
array
microspher
bead
intern
dy
differ
intens
red
infrar
dye
creat
bead
set
uniqu
spectral
ident
bead
set
coupl
specif
oligonucleotid
probe
hybridis
amplifi
target
gener
start
sampl
hybridis
target
label
use
fluoresc
report
dye
microspher
suspens
analys
flow
cytometri
ccd
imag
ident
bead
quantifi
report
probetarget
reaction
microspher
surfac
singlenucleotid
discrimin
locat
near
centr
probe
oligo
probe
modifi
termin
amin
coval
attach
function
carboxyl
group
microspher
surfac
contain
spacer
usual
amin
probe
sequenc
minimis
steric
hindranc
hybridis
microspher
surfac
pcr
primer
typic
design
amplifi
region
target
sequenc
one
primer
pair
biotinyl
end
label
target
strand
amplicon
use
small
target
dna
minimis
potenti
steric
hindranc
affect
hybridis
effici
advers
bead
surfac
dunbar
suspens
bead
assay
format
direct
hybridis
target
dna
amplifi
biotin
label
amplifi
product
denatur
hybridis
specif
probecoupl
bead
set
label
streptavidinlink
fluoresc
report
b
competit
hybridis
label
oligonucleotid
contain
target
sequenc
compet
target
dna
test
sampl
hybridis
specif
probecoupl
bead
set
sampl
target
dna
concentr
invers
proport
beadassoci
report
signal
decreas
sampl
concentr
increas
c
enzymat
assay
chemistri
primer
extens
oligonucleotid
ligat
pcr
use
identifi
target
sequenc
sampl
incorpor
specif
captur
tag
sequenc
target
hybridis
bead
set
bear
complementari
antitag
probe
label
detect
competit
hybridis
similar
direct
hybridis
probe
target
design
howev
competit
assay
format
unlabel
doublestrand
pcramplifi
target
compet
label
singlestrand
oligonucleotid
target
anneal
sequencespecif
captur
probe
microspher
fulton
mcdade
smith
kienker
kettman
anoth
approach
use
sequencespecif
enzymat
reaction
solut
identifi
target
dna
follow
captur
onto
univers
probe
sequenc
bead
surfac
detect
format
involv
incorpor
captur
sequenc
enzymat
step
allow
hybridis
complementari
sequenc
attach
bead
surfac
commonli
use
enzymat
method
sequenc
determin
reli
discrimin
abil
dna
polymeras
dna
ligas
includ
allelespecif
targetspecif
primer
extens
oligonucleotid
ligat
singlebas
chain
extens
targetspecif
pcr
dunbar
taylor
et
al
ye
et
al
chemistri
use
combin
bead
reagent
precoupl
univers
oligonucleotid
captur
sequenc
chosen
ident
hybridis
paramet
minim
crossreact
mahoni
et
al
approach
take
advantag
speed
solutionphas
hybridis
permit
univers
bead
set
use
mani
differ
assay
new
sequenc
target
ad
appropri
captur
sequenc
targetspecif
oligonucleotid
use
enzymat
step
detect
genet
characteris
microbi
pathogen
microarray
method
develop
sever
applic
clinic
microbiolog
laboratori
larg
number
microarray
probe
avail
sever
commerci
platform
allow
highli
multiplex
assay
enabl
detect
broad
rang
organ
andor
discrimin
multipl
genet
element
within
target
speci
miller
tang
current
time
clinic
util
microarray
method
primarili
limit
lack
detail
understand
genet
chang
affect
organ
phenotyp
outcom
infect
rapid
expans
knowledg
multigen
virul
resist
trait
allow
clinic
action
interpret
complex
microarray
data
addit
use
test
patient
care
molecular
method
nextgener
sequenc
yield
addit
genet
data
interpret
target
microarray
method
like
continu
use
conjunct
highthroughput
sequenc
provid
rapid
cheaper
test
particular
indic
sibley
peirano
church
combin
microbi
detect
genotyp
characteris
singl
assay
one
attract
microarray
test
clinic
laboratori
probe
specif
individu
pathogen
utilis
along
genet
marker
resist
element
provid
inform
enabl
earli
optimis
therapi
pathogen
mycobacterium
tuberculosi
phenotyp
suscept
test
take
day
week
complet
empir
treatment
must
initi
interim
neonaki
gitti
krambov
spandido
schann
et
al
often
bacteri
infect
phenotyp
suscept
test
result
avail
within
h
utilis
microarray
test
depend
factor
turnaround
time
cost
failur
rate
empir
antibiot
coverag
note
sensit
may
vari
speci
detect
versu
resist
marker
resist
predict
could
less
reliabl
organ
present
low
titer
thissen
et
al
guidelin
develop
valid
implement
microarray
diagnosi
infecti
diseas
clinic
laboratori
clinic
laboratori
standard
institut
microarray
detect
target
organ
base
conserv
gene
target
amplifi
label
prior
hybridis
detect
therefor
spectrum
detect
depend
number
avail
probe
cover
desir
speci
abil
amplifi
region
interest
use
conserv
primer
singl
target
gene
genet
region
allow
detect
pathogen
interest
microarray
typic
target
one
class
organ
commonli
use
gene
target
list
tabl
includ
ribosom
dna
rdna
bacteria
intern
transcrib
spacer
rdna
fungi
rpob
mycobacteria
baker
et
al
gingera
et
al
mccabe
et
al
possibl
design
primer
pair
complet
conserv
among
prokaryot
speci
gene
target
pcr
may
perform
use
degener
primer
condit
allow
primer
mismatch
still
amplifi
expect
product
therefor
speci
lower
sequenc
ident
primer
region
identifi
requir
higher
number
organ
detect
distantli
relat
organ
may
detect
divers
detect
speci
predict
base
known
sequenc
determin
experiment
baker
et
al
mccabe
et
al
microarray
use
identif
unusu
difficult
identifi
organ
isol
culturebas
method
array
design
particular
pathogen
type
speci
divers
depend
microarray
target
amplif
strategi
use
microarray
appli
common
bacteri
pathogen
often
use
altern
techniqu
biochem
test
malditof
mass
spectrometri
gene
sequenc
avail
yoo
et
al
bacteri
identif
microarray
demonstr
potenti
biothreat
organ
bacillu
anthraci
reliabl
differenti
environment
bacillu
speci
necessari
burton
oshota
silman
food
waterborn
pathogen
bacteria
huang
et
al
maynard
et
al
zhou
et
al
substanti
genotyp
inform
deriv
isol
singlenucleotid
polymorph
snp
level
thierri
et
al
compar
genom
array
allow
sensit
discrimin
relat
isol
detect
virulenceassoci
gene
pathogen
staphylococcu
aureu
spenc
et
al
witney
et
al
slow
grow
fastidi
organ
effici
identifi
microarray
includ
mycobacteria
fukushima
et
al
tobler
pfunder
herzog
frey
altwegg
fungi
campa
et
al
leinberg
et
al
commerci
avail
line
probe
system
use
mycobacteri
spacer
identif
mycobacteri
speci
high
sensit
specif
mij
et
al
tortoli
mariottini
mazzarelli
microarray
also
appli
directli
patient
sampl
aid
diagnosi
assay
sensit
critic
factor
lazzeri
santoro
oggioni
iannelli
pozzi
microarray
also
appli
identif
virus
isol
cultur
use
conserv
target
within
viral
famili
appli
atyp
highli
pathogen
virus
fitzgibbon
sagripanti
xiaop
et
al
identif
organ
grow
blood
cultur
detect
resist
mechan
may
facilit
earlier
target
antimicrobi
therapi
potenti
improv
patient
outcom
reduc
need
use
broadspectrum
antibiot
therapi
microarray
technolog
success
appli
posit
blood
cultur
organ
concentr
high
enough
success
detect
demonstr
molecular
diagnost
techniqu
malditof
mass
spectrometri
yield
similar
inform
day
sooner
standard
biochem
test
sever
commerci
assay
avail
clinic
use
buchan
et
al
laakso
kirveskari
tissari
maki
liesenfeld
lehman
hunfeld
kost
microarray
target
includ
mani
clinic
relev
organ
targetspecif
pathogen
type
determin
initi
gram
stain
differenti
gramposit
cocci
virul
aureu
versu
much
less
pathogen
staphylococcu
epidermidi
lead
signific
treatment
chang
panel
typic
contain
resist
element
meca
staphylococc
methicillin
resist
vana
vancomycinresist
enterococci
palkasantini
putzfeld
cleven
kronk
krut
pasko
et
al
samuel
et
al
gramneg
bacteri
microarray
panel
typic
identifi
enterobacteriacea
speci
pseudomona
aeruginosa
detect
resist
mechan
betalactamas
carbapenemas
sullivan
et
al
accuraci
assay
predict
cephalosporin
carbapenemas
suscept
depend
extent
panel
target
variou
class
betalactamas
gene
local
circul
strain
epidemiolog
panel
also
target
fungal
pathogen
typic
identifi
candida
speci
enabl
optimis
antifung
therapi
aittakorpi
et
al
yoo
et
al
data
still
emerg
optim
approach
translat
blood
cultur
microarray
result
improv
clinic
care
presenc
resist
element
meca
bla
betalactamas
gene
influenc
outcom
host
factor
age
comorbid
major
factor
well
rieg
et
al
appear
intervent
infecti
diseas
pharmaci
practition
need
realis
maximum
benefit
earlier
identif
resist
marker
result
sango
et
al
clinician
becom
familiar
test
decis
algorithm
develop
specialist
consult
may
becom
less
necessari
achiev
potenti
improv
outcom
use
multiplex
respiratori
pathogen
detect
panel
becom
routin
mani
clinic
laboratori
sever
commerci
multiplex
panel
includ
microarray
assay
avail
approv
regulatori
agenc
typic
contain
varieti
respiratori
viru
target
differ
scope
detect
abil
subtyp
ie
inclus
human
coronavirus
subtyp
parainfluenza
adenoviru
well
workflow
handson
time
requir
krunic
merant
yaghoubian
himsworth
janeczko
mahoni
petrich
smieja
compar
studi
shown
differ
assay
sensit
particular
target
particularli
adenoviru
influenza
b
baladallasat
laru
kelli
rigali
pancholi
popowitch
oneil
miller
assay
may
addit
contain
bacteri
target
bordetella
pertussi
chlamydophila
pneumonia
mycoplasma
pneumonia
adapt
diagnos
lower
tract
well
upper
tract
respiratori
infect
lode
et
al
ruggiero
mcmillen
tang
babadi
larger
microarray
panel
allow
diagnosi
case
respiratori
infect
bierbaum
et
al
lin
et
al
simo
et
al
difficult
develop
valid
use
clinic
laboratori
resequenc
microarray
allow
detect
coinfect
strain
discrimin
epidemiolog
track
respiratori
pathogen
microarray
use
panpathogen
detect
method
random
amplif
follow
broadspectrum
target
hybridis
demonstr
larg
amount
divers
viral
flora
diagnos
atyp
infect
human
parainfluenzaviru
rubella
measl
influenza
c
chiu
et
al
kistler
et
al
shen
et
al
fungal
respiratori
infect
attract
target
microarray
test
sinc
pathogen
difficult
grow
requir
rel
long
incub
period
speciesspecif
identif
yeast
mould
dimorph
organ
includ
histoplasma
capsulatum
coccidioid
immiti
detect
singl
test
correl
clinic
microbiolog
diseas
diagnosi
landling
et
al
microarray
particularli
use
diagnosi
immunocompromis
patient
suspect
invas
fungal
infect
detect
difficult
convent
method
spiess
et
al
rapid
detect
mycobacteri
pathogen
also
improv
treatment
decis
commerci
avail
assay
evalu
direct
patient
sampl
test
yield
high
specif
lower
sensit
compar
convent
culturebas
method
tortoli
marcelli
clinic
interpret
respiratori
microarray
test
rel
straightforward
case
viral
detect
symptomat
patient
although
signific
coinfect
less
certain
rapid
molecular
method
use
guid
therapi
pneumonia
base
type
organ
detect
resist
gene
present
clinic
trial
data
yet
publish
endimiani
et
al
convent
method
identif
gastrointestin
pathogen
typic
timeconsum
limit
scope
rel
organ
sever
differ
test
employ
ie
bacteri
cultur
microscopi
parasit
identif
viral
antigen
detect
pcr
test
addit
test
may
still
need
detect
less
common
pathogen
combin
multipl
organ
type
onto
singl
panel
microarray
method
potenti
simplifi
test
protocol
provid
high
sensit
test
panel
includ
speci
commonli
test
convent
method
jin
wen
chen
lin
wang
mix
infect
may
also
detect
inform
regard
infect
parasit
speci
bacteri
subspeci
gener
use
epidemiolog
studi
marotta
et
al
wang
orlandi
stenger
commerci
avail
microarray
test
shown
increas
number
pathogen
detect
compar
convent
method
may
provid
faster
turnaround
time
bacteri
parasit
pathogen
halligan
et
al
mengel
et
al
navidad
griswold
gradu
bhattacharyya
futur
use
may
includ
identif
intestin
microbiota
associ
certain
diseas
state
manipul
probiot
therapi
carey
kirk
ojha
kostrzynska
full
benefit
rapid
molecular
diagnosi
sepsi
requir
use
direct
patient
blood
sampl
allow
shortest
time
action
result
panel
includ
fastidi
organ
difficult
diagnos
use
convent
method
fenollar
raoult
howev
mani
septic
patient
less
one
bacteria
cell
per
millilitr
blood
extract
larg
amount
blood
technic
difficult
klouch
schroder
therefor
sensit
direct
bloodstream
detect
limit
factor
result
still
use
guid
rapid
treatment
decis
huttunen
syrjanen
vuento
aittoniemi
schrenzel
molecular
panel
shown
increas
number
detect
bacteri
infect
cultur
assist
diagnosi
immunocompromis
patient
antimicrobi
therapi
alreadi
initi
burdino
et
al
negoro
et
al
sever
microarraybas
assay
detect
bacteria
yeast
virus
describ
sensit
compar
blood
cultur
debaugni
et
al
shang
chen
wu
du
zhao
wiesingermayr
et
al
optimis
dna
extract
method
primer
set
amplif
condit
need
achiev
sensit
bacteri
cell
per
millilitr
whole
blood
palkasantini
cleven
eiching
kronk
krut
wiesingermayr
jordanalluch
martro
schoenthal
noehamm
microarray
also
use
interrog
host
transcriptom
profil
gener
gene
express
pattern
correl
bacteri
sepsi
inflammatori
state
sutherland
et
al
howev
valid
clinic
algorithm
use
direct
bloodstream
pathogen
detect
confirmatori
data
larg
prospect
studi
demonstr
improv
clinic
outcom
yet
avail
microarray
appli
direct
detect
uropathogen
high
sensit
sinc
quantit
abil
differenti
true
pathogen
urin
contain
mix
flora
limit
liao
et
al
therefor
studi
focus
detect
resist
organ
carbapenemresist
enterobacteriacea
fluoroquinoloneresist
escherichia
coli
nosocomi
bacteria
p
aeruginosa
acinetobact
baumannii
keum
et
al
peter
et
al
yu
et
al
novel
approach
includ
electron
biosensor
array
develop
rapid
detect
uropathogen
minim
sampl
process
eventu
goal
provid
pointofcar
test
capabl
lam
et
al
detect
sexual
transmit
diseas
pathogen
microarray
panel
describ
neisseria
gonorrhoea
chlamydia
trachomati
ureaplasma
urealyticum
use
multiplex
primeramplif
approach
cao
wang
zhang
gao
lee
et
al
shi
wen
chen
wang
howev
commerci
develop
focus
human
papillomaviru
hpv
detect
genotyp
part
cervic
cancer
diagnosi
screen
genotyp
need
distinguish
highrisk
hpv
type
intermedi
lowrisk
type
microarray
varieti
format
develop
identifi
known
genotyp
hpv
infect
cervic
cytolog
swab
specimen
albrecht
et
al
feng
et
al
shengunth
rebel
applic
detect
sensit
less
import
abil
discrimin
lowrisk
patient
carcinoma
like
progress
clinic
typic
assess
use
abnorm
histolog
cervic
intraepitheli
neoplasia
cin
grade
higher
test
compar
hybrid
captur
ii
assay
show
similar
improv
analyt
sensit
cho
kim
bae
ahn
park
et
al
current
realtim
pcrbase
coba
hpv
assay
evalu
larg
trial
specif
approv
us
food
drug
administr
primari
cervic
cancer
screen
improv
sensit
greater
greater
compar
liquidbas
cytolog
castl
et
al
wright
et
al
detect
microarray
best
suit
identifi
noncommens
pathogen
nonsteril
site
infect
wide
rang
organ
steril
site
report
detect
cutan
mycobacteri
infect
superfici
invas
mycos
campa
et
al
carlo
tang
adler
kovarik
sato
et
al
profil
microbiota
heal
wound
show
associ
acinetobact
wound
failur
entericassoci
flora
success
heal
identif
prosthet
joint
infect
enhanc
molecular
techniqu
pcr
sequenc
microarraybas
assay
enhanc
detect
patient
previous
treat
antibiot
metso
et
al
microarray
appli
diagnosi
bacteri
mening
demonstr
detect
case
convent
method
alon
although
method
standardis
potenti
falseposit
sampl
contamin
ben
et
al
liu
han
huang
zhu
rafi
chandramuki
mani
satishchandra
shankar
identif
differenti
fungal
pathogen
cryptococcu
neoforman
cryptococcu
gattii
possibl
cerebrospin
fluid
method
need
optimis
sensit
detect
bover
et
al
organ
caus
viral
mening
enceph
target
viral
microarray
probe
human
herpesvirus
measl
mump
enterovirus
boriskin
et
al
levequ
et
al
specialis
microarray
also
develop
highli
pathogen
virus
chikungunya
yellow
fever
dengu
hantaviru
emerg
zoonot
agent
xiaop
et
al
larg
number
research
studi
use
microarray
method
determin
presenc
virul
factor
genet
element
bacteria
techniqu
import
investig
pathogen
public
health
signific
salmonella
legionella
outbreak
investig
exampl
multist
listeria
outbreak
associ
cantaloup
gomgnimb
et
al
gronlund
et
al
laksanalamai
et
al
clinic
diagnost
standpoint
bacteri
genotyp
rare
need
special
circumst
genotyp
assist
investig
infect
immunodefici
patient
instanc
determin
whether
individu
streptococcu
pneumonia
infect
previous
vaccin
strain
includ
vaccin
acquir
knowledg
clinic
relev
certain
bacteri
genotyp
virul
factor
predict
diseas
sever
genotyp
could
becom
use
track
diseas
epidemiolog
indic
aggress
treatment
certain
strain
clostridium
difficil
ribotyp
knetsch
et
al
tuberculosi
strain
type
import
public
health
control
effort
pcrbase
test
presenc
variabl
direct
repeat
spacer
oligonucleotid
spoligotyp
wide
accept
techniqu
adopt
microarray
platform
rapid
afford
method
cowan
diem
brake
crawford
ruettger
et
al
genom
delet
snp
stabl
tuberculosi
clone
make
potenti
surveil
method
approach
studi
pathogenesi
strain
known
delet
katomaeda
et
al
mahasirimongkol
et
al
clinic
microarray
often
contain
marker
antibiot
resist
well
see
section
like
bacteria
microarray
use
determin
strain
epidemiolog
investig
virul
factor
fungal
pathogen
balaje
sigler
brandt
garaizar
brena
bikandi
rementeria
ponton
exampl
gene
express
analysi
yield
candid
virul
factor
c
gattii
outbreak
strain
ngamskulrungroj
price
sorrel
perfect
meyer
except
hpv
genotyp
describ
section
clinic
viral
genotyp
yield
prognost
inform
use
guid
treatment
decis
use
epidemiolog
research
purpos
microarray
target
specif
viral
famili
panvir
use
unbias
amplif
hybridis
conserv
sequenc
region
wang
et
al
hepat
c
viru
hcv
genotyp
import
determin
optim
treatment
regimen
microarraybas
method
commerci
avail
duart
et
al
nadarajah
khan
miller
brook
park
et
al
hepat
b
viru
hbv
genotyp
influenc
treatment
respons
microarray
method
differenti
variou
genotyp
gauthier
et
al
virus
microarray
assay
gener
epidemiolog
inform
circul
strain
includ
segment
origin
influenza
rotaviru
genom
type
emerg
virus
gardner
ja
honma
et
al
paulin
et
al
abil
accur
predict
phenotyp
resist
bacteria
genet
makeup
depend
larg
panel
resist
marker
along
predict
algorithm
antibiot
drug
class
drug
microarray
well
suit
detect
resist
gene
cassett
notabl
betalactamas
carbapenemas
also
detect
snp
associ
drug
resist
test
reason
high
sensit
specif
detect
known
resist
element
often
differenti
function
nonfunct
gene
fail
identifi
mutat
type
porin
mutant
affect
resist
profil
cuzon
naa
bogaert
glupczynski
nordmann
frye
et
al
naa
cuzon
truong
bernabeu
nordmann
current
avail
panel
gramneg
organ
yield
correl
approxim
posit
microarray
result
antimicrobi
resist
microarrayneg
result
correl
antimicrobi
sensit
card
et
al
predict
rate
vari
per
drug
class
gener
better
plasmidmedi
resist
element
chromosom
mutat
well
suit
identif
bacteri
produc
specif
extendedspectrum
betalactamas
carbapenemas
infect
control
resist
monitor
naa
cuzon
bogaert
glupczynski
nordmann
quinolon
resist
e
coli
identifi
known
snp
gyra
though
correl
phenotyp
resist
shown
limit
number
isol
barl
et
al
yu
susa
knabb
schmid
bachmann
microarray
target
genotyp
antibiot
resist
nosocomi
gramneg
pathogen
includ
efflux
regul
dna
gyras
betalactamas
aminoglycosidemodifi
enzym
carbapenemas
genotypephenotyp
correl
p
aeruginosa
select
strain
multidrugresist
baumannii
dalli
et
al
mutat
helicobact
pylori
rrna
gene
associ
clarithromycin
resist
also
detect
microarray
test
chen
li
yu
gramposit
pathogen
aureu
microarray
use
detect
clinic
relev
resist
mutat
sever
antibiot
strommeng
et
al
correl
array
detect
phenotyp
resist
approxim
penicillin
methicillin
aminoglycosid
macrolid
lincosamid
resist
phenotyp
test
zhu
et
al
techniqu
nextgener
sequenc
high
correl
microarray
method
detect
bacteri
resist
mutat
gener
current
data
support
abil
molecular
techniqu
detect
known
resist
mutat
prospect
test
larg
number
clinic
isol
varieti
locat
determin
perform
characterist
rel
convent
phenotyp
suscept
test
veeneman
et
al
assay
turnaround
time
manual
manipul
step
gener
reduc
test
result
avail
clinic
relev
time
frame
mycobacteri
resist
microarray
platform
focus
tuberculosi
clinic
signific
pathogen
group
phenotyp
test
delay
due
organ
slow
growth
molecular
techniqu
yield
rapid
detect
resist
mutat
allow
earlier
transit
secondlin
treatment
rifampinresist
strain
certain
known
point
mutat
rearrang
rpob
gene
caoili
et
al
yue
et
al
approxim
isoniazidresist
strain
katg
mutat
inha
mutat
kim
et
al
yao
et
al
pyrazinamid
resist
associ
mutat
pnca
gene
though
resist
strain
mutat
gene
denkin
volokhov
chizhikov
zhang
microarraydetect
embb
mutat
found
ethambutolresist
strain
mour
et
al
secondlin
tuberculosi
therapi
mutat
rpsl
found
associ
streptomycin
resist
though
sensit
low
due
limit
microarray
gene
coverag
studi
found
sensit
detect
resist
rifampin
isoniazid
ethambutol
linger
et
al
secondlin
drug
microarray
yield
detect
resist
mutat
includ
fluoroquinolon
kanamycin
capreomycin
zimenkov
et
al
tuberculosi
microarray
develop
detect
resist
polymorph
mycobacterium
lepra
matsuoka
et
al
overal
microarray
method
detect
resist
mycobacteri
speci
promis
still
requir
test
larg
number
geograph
divers
isol
determin
abil
guid
therapeut
choic
sever
mechan
antifung
resist
yeast
identifi
mani
involv
overexpress
gene
encod
drug
target
efflux
pump
transport
gene
express
microarray
identifi
gene
associ
azol
resist
candida
albican
use
identifi
specif
mutat
affect
promot
express
yan
et
al
increas
express
ergosterol
biosynthesi
gene
import
amphotericin
b
resist
c
albican
azol
resist
candida
glabrata
associ
upregul
pleiotrop
drug
resist
network
locu
barker
et
al
tsai
et
al
knowledg
gain
specif
mutat
caus
upregul
microarray
use
identifi
strain
carri
known
resist
mutat
detect
known
resist
mutat
virus
amen
microarray
test
implement
econom
method
full
gene
sequenc
resourcelimit
set
test
hiv
resist
proteas
revers
transcriptas
gene
yield
concord
sequenc
discrep
case
due
increas
sensit
microarray
sequenc
method
zhang
cai
et
al
hbv
microarray
target
accur
identifi
mutat
associ
lamivudin
resist
microarray
design
detect
mutat
neuraminidas
matrix
gene
influenza
identifi
strain
high
accuraci
zhang
liu
wang
chen
wang
viral
resist
mutat
confer
resist
therapi
discov
microarray
offer
costeffect
method
detect
clinic
epidemiolog
set
microarray
offer
conveni
method
interrog
specif
pathogen
sequenc
scale
ten
hundr
thousand
oligonucleotid
probe
sever
technolog
platform
avail
includ
solidst
electron
suspens
bead
microarray
multipl
variat
probe
synthesi
chemistri
linkag
data
collect
analysi
format
sampl
typic
amplifi
use
multiplex
primer
set
follow
hybridis
wash
signal
detect
microarray
adopt
microbi
detect
genotyp
antimicrobi
resist
gene
detect
directli
clinic
sampl
isol
organ
limit
detect
compar
molecular
techniqu
still
may
equival
largevolum
cultur
techniqu
blood
cultur
microarray
assay
limit
set
avail
probe
sequenc
may
detect
unusu
sequenc
variant
novel
genet
element
clinic
signific
care
consider
must
taken
assay
design
valid
distinguish
close
relat
speci
differ
virul
ie
pneumonia
vs
viridan
streptococcu
ensur
relev
circul
strain
contain
sequenc
variat
adequ
detect
identifi
ideal
probe
set
updat
reflect
chang
genotyp
strain
epidemiolog
perform
microarray
test
need
determin
differ
specimen
type
matric
may
encount
clinic
test
microarray
test
well
suit
offer
panel
approach
diagnos
specif
patient
present
respiratori
viral
infect
infecti
diarrhoea
also
discrimin
clinic
isol
genotyp
use
track
epidemiolog
outbreak
investig
inform
becom
avail
regard
specif
gene
pathway
involv
antimicrobi
resist
begin
abl
predict
suscept
pattern
base
sequenc
interrog
particular
organ
advanc
autom
microarray
process
method
genotypephenotyp
predict
algorithm
test
becom
use
adjunct
replac
convent
suscept
test
allow
rapid
select
target
therapi
infecti
diseas
